| 摘要 |
FIELD: medicine.SUBSTANCE: group of invention refers to a method for testing graft versus host reaction involving measuring the CCL8 protein level in a sample taken from an individual as a diagnostic or control criteria of the course of graft versus host reaction, as well as to a diagnostic reagent of graft versus host reaction containing the anti-CCL8 antibody.EFFECT: enabled diagnosis of the beginning of graft versus host reaction and monitoring of progression, particularly differential diagnosis of graft versus host reaction and an infectious disease.6 cl, 17 dwg, 9 ex |
